The World Market for Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins: A 2011 Global Trade Perspective
ICON Group International, May 2010, Pages: 201
This report was created for strategic planners, international executives and import/export managers who are concerned with the market for medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins for those countries serving the world market via exports or supplying from various countries via imports. I do so for the current year based on a variety of key historical indicators and econometric models.
On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins? What is the dollar value of these imports? How much do the imports of medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?
In what follows, Chapter 2 begins by summarizing the regional markets for imported and exported medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins. The total level of imports and exports on a worldwide basis, and those for each region, is based on a model which aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on both demand- and supply-side dynamics, market shares by country of origin are then calculated across each country market destination. These shares lead to a volume of import and export values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each market and the shares that countries are likely to receive this year. From these figures, rankings are calculated to allow managers to prioritize markets. In this way, all the figures provided in this report are forecasts that can be combined with internal information for strategic planning purposes.
After the worldwide summary in Chapter 2 of both imports and exports, Chapter 3 details the exports of medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins, for each individual country. Chapter 4 does the same, but for imports of medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins for all countries in the world. In all cases, the total dollar volume and percentage share values by major trading partner are provided. Combined, Chapters 3 and 4 present the complete picture for imports and exports of medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins to and from all major countries in the world. Of the 150 countries considered, if a country is not reported here it is therefore estimated to have only a negligible level of trade in medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins (i.e. their market shares are close or equal to zero percent). "Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defined "medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins" is 54219 .
1 METHODOLOGY
1.1 Our Approach
2 THE WORLD MARKET
2.1 Exports
2.1.1 The World Market: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins Export Supplies in 2011
2.2 Imports
2.2.1 The World Market: Imported Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins in 2011
3 EXPORTS
3.1 Africa: Export Supplies of Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins
3.1.1 Executive Summary
3.1.2 Egypt
3.1.3 Kenya
3.1.4 Mali
3.1.5 Mauritius
3.1.6 Morocco
3.1.7 Senegal
3.1.8 Sierra Leone
3.1.9 South Africa
3.1.10 Uganda
3.1.11 Zambia
3.1.12 Zimbabwe
3.2 Asia: Export Supplies of Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins
3.2.1 Executive Summary
3.2.2 Bangladesh
3.2.3 China
3.2.4 Hong Kong
3.2.5 India
3.2.6 Indonesia
3.2.7 Japan
3.2.8 Malaysia
3.2.9 Philippines
3.2.10 Singapore
3.2.11 South Korea
3.2.12 Sri Lanka
3.2.13 Taiwan
3.2.14 Thailand
3.2.15 Vietnam
3.3 Europe: Export Supplies of Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins
3.3.1 Executive Summary
3.3.2 Austria
3.3.3 Belarus
3.3.4 Belgium
3.3.5 Bosnia and Herzegovina
3.3.6 Bulgaria
3.3.7 Croatia
3.3.8 Cyprus
3.3.9 Czech Republic
3.3.10 Denmark
3.3.11 Estonia
3.3.12 Finland
3.3.13 France
3.3.14 Germany
3.3.15 Greece
3.3.16 Hungary
3.3.17 Iceland
3.3.18 Ireland
3.3.19 Italy
3.3.20 Kazakhstan
3.3.21 Latvia
3.3.22 Lithuania
3.3.23 Luxembourg
3.3.24 Macedonia
3.3.25 Malta
3.3.26 Moldova
3.3.27 Norway
3.3.28 Poland
3.3.29 Portugal
3.3.30 Romania
3.3.31 Russia
3.3.32 Slovakia
3.3.33 Slovenia
3.3.34 Spain
3.3.35 Sweden
3.3.36 the Netherlands
3.3.37 Ukraine
3.4 Latin America: Export Supplies of Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins
3.4.1 Executive Summary
3.4.2 Argentina
3.4.3 Bolivia
3.4.4 Brazil
3.4.5 Chile
3.4.6 Colombia
3.4.7 Costa Rica
3.4.8 Ecuador
3.4.9 El Salvador
3.4.10 Guatemala
3.4.11 Mexico
3.4.12 Nicaragua
3.4.13 Panama
3.4.14 Paraguay
3.4.15 Peru
3.4.16 Uruguay
3.4.17 Venezuela
3.5 North America & the Caribbean: Export Supplies of Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins
3.5.1 Executive Summary
3.5.2 Barbados
3.5.3 Canada
3.5.4 Cuba
3.5.5 Dominican Republic
3.5.6 the United States
3.6 Oceana: Export Supplies of Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins
3.6.1 Executive Summary
3.6.2 Australia
3.6.3 New Zealand
3.7 the Middle East: Export Supplies of Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins
3.7.1 Executive Summary
3.7.2 Armenia
3.7.3 Israel
3.7.4 Jordan
3.7.5 Oman
3.7.6 Pakistan
3.7.7 Saudi Arabia
3.7.8 Turkey
4 IMPORTS
4.1 Africa: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins Imports in 2011
4.1.1 Executive Summary
4.1.2 Botswana
4.1.3 Cape Verde
4.1.4 Cote d'Ivoire
4.1.5 Egypt
4.1.6 Ethiopia
4.1.7 Kenya
4.1.8 Madagascar
4.1.9 Malawi
4.1.10 Mauritius
4.1.11 Senegal
4.1.12 South Africa
4.1.13 Tunisia
4.1.14 Uganda
4.1.15 Zambia
4.2 Asia: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins Imports in 2011
4.2.1 Executive Summary
4.2.2 China
4.2.3 Hong Kong
4.2.4 Indonesia
4.2.5 Japan
4.2.6 Malaysia
4.2.7 Maldives
4.2.8 Mongolia
4.2.9 Singapore
4.2.10 South Korea
4.2.11 Thailand
4.3 Europe: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins Imports in 2011
4.3.1 Executive Summary
4.3.2 Austria
4.3.3 Belarus
4.3.4 Belgium
4.3.5 Bosnia and Herzegovina
4.3.6 Croatia
4.3.7 Cyprus
4.3.8 Czech Republic
4.3.9 Denmark
4.3.10 Estonia
4.3.11 Finland
4.3.12 France
4.3.13 Georgia
4.3.14 Germany
4.3.15 Greece
4.3.16 Iceland
4.3.17 Ireland
4.3.18 Italy
4.3.19 Latvia
4.3.20 Lithuania
4.3.21 Luxembourg
4.3.22 Macedonia
4.3.23 Malta
4.3.24 Moldova
4.3.25 Norway
4.3.26 Romania
4.3.27 Russia
4.3.28 Slovakia
4.3.29 Slovenia
4.3.30 Sweden
4.3.31 the Netherlands
4.4 Latin America: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins Imports in 2011
4.4.1 Executive Summary
4.4.2 Argentina
4.4.3 Belize
4.4.4 Bolivia
4.4.5 Brazil
4.4.6 Colombia
4.4.7 Ecuador
4.4.8 El Salvador
4.4.9 Guatemala
4.4.10 Honduras
4.4.11 Mexico
4.4.12 Panama
4.4.13 Peru
4.4.14 Uruguay
4.5 North America & the Caribbean: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins Imports in 2011
4.5.1 Executive Summary
4.5.2 Anguilla
4.5.3 Barbados
4.5.4 Canada
4.5.5 Jamaica
4.5.6 St. Lucia
4.5.7 the Bahamas
4.5.8 the United States
4.6 Oceana: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins Imports in 2011
4.6.1 Executive Summary
4.6.2 Australia
4.6.3 Fiji
4.6.4 New Caledonia
4.6.5 New Zealand
4.7 the Middle East: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins Imports in 2011
4.7.1 Executive Summary
4.7.2 Armenia
4.7.3 Azerbaijan
4.7.4 Bahrain
4.7.5 Israel
4.7.6 Jordan
4.7.7 Kyrgyzstan
4.7.8 Pakistan
4.7.9 Saudi Arabia
4.7.10 Turkey
4.7.11 Yemen
5 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS
5.1 Disclaimers & Safe Harbor
5.2 ICON Group Ltd. User Agreement Provisions
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
